Used in pharmaceutical research as a potential active ingredient in the development of central nervous system (CNS) agents, particularly for psychiatric and neurological disorders. Shows affinity for serotonin and dopamine receptors, suggesting application in treatments for depression, anxiety, or schizophrenia. Also investigated for its potential as a selective receptor modulator with improved efficacy and fewer side effects compared to existing drugs. Its structure supports blood-brain barrier penetration, making it suitable for targeting brain-specific conditions. Currently utilized in preclinical studies to optimize pharmacokinetics and safety profiles.